Key Takeaways
- Eighth straight quarter of margin-led earnings improvement: EBITDA grew 5% in Q2 and 9% in H1, with margins expanding 120 bps and 80 bps respectively, despite higher input, freight, and energy costs.
- A new "structural debt" lens reframes the balance sheet: Management introduced a supplementary metric showing structural debt at ~$800 million (0.7x gearing), arguing that working capital is "cash-alike" and the true debt burden is far lower than reported net debt of ~$3 billion.
- China is undergoing structural supply-side change, not just a cycle: Glufosinate prices are rising, and management expects the same for many other products, driven by capacity discipline, stricter environmental compliance, and a one-company-one-brand policy.
- UPL Corp volumes fell 16% as the company chose margin quality over chasing volume: Grower liquidity constraints, cautious channel purchasing, and competitive pricing hit volumes, but the company held pricing discipline and tighter credit, especially in Brazil/LATAM.
- What to watch next quarter: Whether the seasonally larger H2 delivers the promised volume recovery, how quickly higher Chinese active ingredient prices flow through to UPL's P&L once older lower-cost inventory liquidates, and any material update on the stalled reorganization.
Margin Quality & Earnings Resilience
- Contribution margin expansion was broad-based: Better product and platform mix, strong brand equity, new product launches, geographical diversification, and global distribution capabilities all contributed, offsetting higher input and freight costs.
- SG&A fell 2% YoY driven by operational excellence and cost optimization, including a near-3x increase in GBS headcount over two years that shifted jobs from high-cost jurisdictions to Pune and Mauritius.
- Employee costs dropped ~15% YoY from GBS leverage, FX tailwinds from currency devaluation in certain jurisdictions, and benefits from target operating model changes where costs were booked in the prior year.
- H1 operational PATMI grew 33% YoY to INR441 crore, driven by margin-led EBITDA growth and a lower effective tax rate.
- UPL Corp chose margin discipline over volume in a tough market: Q2 contribution margin fell 120 bps to 33.9% on higher input manufacturing costs and pricing pressure, but H1 contribution margin still improved 90 bps to 35.8% despite revenue being 2% lower, because the company refused to chase unprofitable sales in Brazil and LATAM.
Bikash Prasad: "Agricultural markets faced an exceptionally difficult season across key geographies, and we made a conscious choice not to compromise on the quality of the business."
Platform-Level Performance
| Platform | Revenue Trend | Key Drivers |
|---|---|---|
| SUPERFORM | ▲ +28% YoY | Pricing +26%, volumes +2%; specialty chemicals +50% (volumes +33%) driven by lubricant additive contract manufacturing and new product commercialization. EBIT +39%, margin +70 bps to 9%. |
| Advanta | ▲ +12% YoY | Field corn in Argentina, LATAM, Indonesia; sunflower and grain sorghum in Argentina; post-harvest business. Contribution margin +110 bps to 58.8%; EBITDA +19%, margin +150 bps to 27.2%. H1 revenue +18%, EBITDA +21%. |
| UPL SAS (India) | ▬ +1% YoY | Volumes -8% on deficient rainfall, delayed sowing, compressed application windows, and lower pest/disease incidence; pricing +9% from calibrated actions. Contribution margin +60 bps to 35.6%; H1 EBITDA +20% with margin +430 bps to 26.8%. Hyperscale brands grew 80% YoY in H1. |
| UPL Corp (Global CP) | ▼ -8% YoY | Volumes -16%, pricing -2%, partly offset by +10% currency. North America grew on new differentiated products; Brazil/LATAM declined on grower liquidity constraints and price discipline; Europe dampened by severe heat wave; Rest of World grew led by APAC and South Africa. |
- Advanta acquired Misr Hytech Seed in Egypt for ~$110 million, strengthening its field corn presence across Egypt and the wider Middle East/Africa; transaction still under regulatory approval.
- UPL SAS hyperscale portfolio is scaling fast: Brands like Centurion, Canora EZ, Brucia, and Harmetry delivered 80% YoY growth in H1, supporting both pricing and mix even as overall volumes declined.
- India EBITDA grew ~20% in H1 despite El Niño volume softness because relatively new differentiated products scaled up with greater margins, and timely pricing increases responded to anticipated cost increases; the price impact will fade as costs catch up, but the portfolio impact will remain.
The China Supply-Side Thesis
- Glufosinate prices from China have risen, improving UPL's global competitiveness, but lower-cost inventory bought pre-conflict is still liquidating in LATAM and US markets; higher prices will take effect and a bigger volume unlock will happen only once that older material clears.
- Management sees structural change, not a temporary cycle: Chinese companies were losing money for several quarters, there is a concerted effort to increase pricing, environmental compliance is getting stricter, a one-company-one-brand policy is being enforced, and capacity discipline is emerging. These factors are expected to drive price increases across many products, not just glufosinate.
- The pass-through timing is uncertain: The benefit to UPL's P&L depends on how quickly older lower-cost inventory liquidates in the Americas, which makes the pace of margin recovery in UPL Corp a variable to track rather than a given.
Ashish Dobhal: "I think some of these things are very structural in China. I think essentially, what we have seen in glufosinate will happen with a lot of other products also in the market, which come out of China."
Balance Sheet, Debt & the New "Structural Debt" Metric
- Net debt rose $312 million YoY to ~$3 billion, driven by working capital, planned CapEx, and investment in JVs and associates. Net working capital at 145 days was 27 days higher YoY: inventory days +16 on higher input costs, lower CP volumes, deliberate H2 buildup, longer transit times, and currency translation; receivable days +4; payable days -6.
- Management introduced "structural debt" as a supplementary analytical view: defined as net debt minus net working capital, it stands at ~$800 million with 0.7x gearing. The argument is that working capital is "cash-alike" and converts within the same operating cycle, so investors should focus on the residual structural debt rather than the headline net debt number.
- This is explicitly not a replacement for reported metrics or lender covenants, and management was careful to frame it as an additional lens, not a substitution.
- H1 free cash flow to equity fell to INR508 crore from INR1,733 crore last year, reflecting higher planned CapEx and investment of INR703 crore and a one-time tax refund of INR742 crore in the base quarter.
- Debt refinancing was executed well ahead of schedule: $400 million of the $500 million term loan maturing December 2026 was refinanced to FY 2032; the remaining $100 million was paid from existing lines. No debt obligations fall due until March 2027; the next maturity is FY 2028 with $776 million total ($500 million term loan, ~$276 million bonds).
- Medium-term gearing target remains 1.5x, but management declined to provide specific full-year net debt or gearing guidance, citing macro uncertainty, raw material price movements, and Q3 grower demand as variables that could push the number lower or slightly higher.
Bikash Prasad: "Working capital is like a cash alike. It is converted into cash within the same operating cycle. So I think we should not be unduly worried about the level of working capital and hence the net debt. What you need to understand is the difference between net debt and the working capital, which is the structural debt."
Macro Backdrop & Demand Environment
- Headwinds were severe and simultaneous: Geopolitical tensions in West Asia kept freight, energy-linked inputs, and active ingredient costs elevated; US tariff-related uncertainties weighed on trade flows; generic supply and competitive intensity limited pricing power; El Niño affected plantings and application windows across India, Europe, and the Southern Cone; Brazil saw tight channel liquidity and restricted credit driving just-in-time purchasing that pushed demand later.
- Positives are building: Crop commodity prices (soybean, wheat, corn, cotton) are up 25%-35% over the last 12 months, and channel inventories are broadly at normal levels, setting the stage for gradual improvement in grower sentiment and farm economics.
- El Niño is strengthening and is expected to intensify between November and March, which could further disrupt planting and application windows in key markets.
- Associates posted a INR130 crore loss this quarter, with two subsidiaries still underperforming; management is working on fixing them and expects associates to be break-even to a $10 million loss going forward, against a normal distribution margin of 4% to 5%.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY 2027 revenue and EBITDA growth | Revenue growth 7%-11%, EBITDA growth 10%-14% | FY 2027, subject to no further adverse weather including El Niño and no major escalation in West Asia conflict |
| Medium-term gearing target | 1.5x | Medium-term; no specific date given |
| Full-year CapEx and investment | Approximately $425 million | FY 2027 |
| Associates loss reduction | Break-even to $10 million loss (from INR130 crore loss this quarter) | No specific date; "working on fixing them" |
| SUPERFORM revenue and EBIT growth | Momentum to continue for next two quarters if macro remains stable | Next two quarters |
| Advanta India growth pickup | Expect to pick up growth from Q4 onward | Q4 FY 2027 onward |
| Reorganization update | Will make appropriate disclosures when there are material developments | No timeline given |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue | ₹11,860 cr, 1% lower YoY; volumes -10%, pricing flat, currency +9% |
| Contribution margin | 42.9%, expanded 100 bps YoY |
| EBITDA | ₹2,312 cr, grew 5% YoY |
| EBITDA margin | 19.5%, expanded 120 bps YoY |
| Operational PATMI | ₹422 cr, ₹11 cr ahead of last year |
| H1 FY27 revenue | ₹22,041 cr, grew 4% YoY |
| H1 FY27 EBITDA | ₹3,812 cr, grew 9% YoY; margin expanded 80 bps to 17.3% |
| H1 FY27 operational PATMI | ₹441 cr, grew 33% YoY, adjusted for exceptional items |
| Net debt | ~$3 bn, $312 mn higher YoY |
| Net debt to EBITDA (trailing 12-month) | 2.9x, vs 2.7x last year |
| Net working capital | 145 days, 27 days higher YoY; inventory +16 days, receivables +4 days, payables -6 days |
| Structural debt | ~$800 mn, 0.7x gearing, flat vs March |
| H1 FY27 free cash flow to equity (adjusted) | ₹508 cr, vs ₹1,733 cr last year; base year included ₹742 cr one-time tax refund |
| SUPERFORM revenue | ₹3,579 cr, grew 28% YoY; pricing +26%, volumes +2% |
| SUPERFORM EBIT | ₹323 cr, grew 39% YoY; margin improved 70 bps to 9% |
| UPL Corp revenue | ₹7,972 cr, 8% lower YoY; volumes -16%, pricing -2%, currency +10% |
| UPL Corp EBITDA margin | 13.6% |
| UPL SAS revenue | ₹921 cr, grew 1% YoY; volumes -8%, pricing +9% |
| UPL SAS EBITDA | ₹214 cr, grew 3% YoY; margin 23.2% |
| Advanta revenue | ₹1,875 cr, grew 12% YoY |
| Advanta EBITDA | ₹510 cr, grew 19% YoY; margin expanded 150 bps to 27.2% |
| Advanta contribution margin | 58.8%, expanded 110 bps YoY |
| UPL SAS hyperscale brands growth (H1) | 80% YoY growth |
| Crop commodity prices (soybean, wheat, corn, cotton) | Up 25%–35% over last 12 months |
| Advanta acquisition of Misr Hytech (Egypt) | ~$110 mn for 99.98% stake, subject to closing |
| Term loan refinancing | $400 mn of $500 mn Dec 2026 maturity refinanced to FY 2032 |
| Full-year CapEx and investment guidance | ~$425 mn |
| Medium-term gearing target | 1.5x; last year ended around 1.6x |
| Factoring at H1 end | ~$70 mn lower than last year |
| Loss from associates | ₹130 cr impact this quarter |
| FY 2027 guidance (revenue growth) | 7%–11% |
| FY 2027 guidance (EBITDA growth) | 10%–14% |
| H1 revenue contribution split | ~40% of full year; H2 ~60% |
| Employee cost | ₹1,240 cr this quarter |
| Other income reversal plus revenue adjustment (per analyst) | ~₹130 cr benefit, vs group PAT of ~₹420 cr (per an analyst's math) |